Presentation Information

[1P-771]Frontiers in COVID-19 Patient Management: High-throughput Screening, Virus Pathogenicity, and Drug Resistance

○Yosuke Hirotsu1 (1. Genome Analysis Center, Yamanashi Central Hospital)

Password required to view


Comment

To browse or post comments, you must log in.Log in